Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III–IV melanoma in phase III trial E1609
Year: 2022
Type: book-chapter
Source: Quality of Life Research
Authors: Laurie E. McLouth, Yue Zheng, Stephanie Smith, F. Stephen Hodi, Uma N. Rao, Gary I. Cohen, Thomas T. Amatruda, Shaker R. Dakhil, Brendan D. Curti, Ibrahim Nakhoul, Sreenivasa R. Chandana, Charles L. Bane, David E. Marinier, Sandra J. Lee, Vernon K. Sondak, John M. Kirkwood, Ahmad A. Tarhini, Lynne I. Wagner
Institutions: University of Kentucky, Markey Cancer Center, Dana-Farber Cancer Institute, St. Joseph’s Candler Hospital, Harvard University, Dana-Farber/Harvard Cancer Center, UPMC Hillman Cancer Center, Greater Baltimore Medical Center, Minnesota Oncology, Ascension Via Christi, Providence Portland Medical Center, Michigan Cancer Research Consortium, Good Samaritan Hospital, Gundersen Health System, Moffitt Cancer Center, Wake Forest Baptist Comprehensive Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G1061450929, G1105606313, G1141282278, G1542843696, G1815686716, G1881030900, ECOG-ACRIN Network Group Operations Center, G1938688226, G1988210332, G2167093779, G2280802303, G2526390019, G2727264567, G2843309668, G3059322855, G3231584006, G3475623468, SWOG Network Group Operations Center of the NCTN, G3816780699, G402704888, G4188603810, NRG Oncology Network Group Operations Center, G434901823, G4449591032, ECOG-ACRIN NCORP Research Base, G5009787934, G545695214, G557084418, NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care, G580335595, G5876975346, G6153186573, G6269845307, Cancer Research Consortium of West Michigan (CRCWM), G6705915398, ECOG-ACRIN Network Group Statistics and Data Management Center, G6880957883, G7367166394, Johns Hopkins University NCTN Lead Academic Site Program, Postdoctoral Training Program in Cancer Survivorship, Wisconsin NCI Community Oncology Research Program (WiNCORP), G8220656038, Alliance for Clinical Trials in Oncology Operations Center, Institutional Career Development Core
OpenAlex ID: W4293315213